Thaçi, Diamant, et al. “Absolute Eczema Area and Severity Index Responses With Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis: A Secondary Analysis of Two Phase 3 Trials”. Acta Dermato-Venereologica, vol. 106, May 2026, pp. adv-2025, doi:10.2340/actadv.v106.adv-2025-0160.